Cognitive and academic outcomes in long-term survivors of infantile-onset Pompe disease: A longitudinal follow-up

Molecular Genetics and Metabolism

Volumn 121, Issue 2, 2017, Pages 127-137

  Spiridigliozzi, Gail A ^a   Keeling, Lori A ^b   Stefanescu, Mihaela ^a   Li, Cindy ^a   Austin, Stephanie ^a   Kishnani, Priya S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Academic; Cognitive; Infantile onset Pompe; Visual motor integration

Indexed keywords

ACADEMIC ACHIEVEMENT; ADOLESCENT; ARTICLE; BEERY-BUKTENICA DEVELOPMENTAL TEST OF VISUAL-MOTOR INTEGRATION; CHILD; CLINICAL ARTICLE; COGNITION; ENZYME REPLACEMENT; FEMALE; FOLLOW UP; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; INTELLIGENCE TEST; LANGUAGE ABILITY; LEARNING DISORDER; LONGITUDINAL STUDY; MALE; MOTOR COORDINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSORIMOTOR INTEGRATION; VISION; WECHSLER INTELLIGENCE SCALE; COMPLICATION; MOTOR PERFORMANCE; ONSET AGE; PATHOPHYSIOLOGY; SURVIVOR;

ALPHA GLUCOSIDASE; GAA PROTEIN, HUMAN;

ACADEMIC PERFORMANCE; AGE OF ONSET; ALPHA-GLUCOSIDASES; CHILD; CHILD, PRESCHOOL; COGNITION; ENZYME REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; INTELLIGENCE TESTS; LEARNING DISORDERS; LONGITUDINAL STUDIES; MALE; MOTOR SKILLS; SURVIVORS;

EID: 85019051286     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2017.04.014     Document Type: Article

References (37)

1. Kishnani, P.S., Beckemeyer, A.A., New therapeutic approaches for Pompe disease: enzyme replacement therapy and beyond. Pediatr. Endocrinol. Rev. 12:Suppl. 1 (2014), 114–124.
2. Kishnani, P.S., Corzo, D., Nicolino, M., Byrne, B., Mandel, H., Hwu, W.L., Leslie, N., Levine, J., Spencer, C., McDonald, M., Li, J., Dumontier, J., Halberthal, M., Chien, Y.H., Hopkin, R., Vijayaraghavan, S., Gruskin, D., Bartholomew, D., van der Ploeg, A., Clancy, J.P., Parini, R., Morin, G., Beck, M., De la Gastine, G.S., Jokic, M., Thurberg, B., Richards, S., Bali, D., Davison, M., Worden, M.A., Chen, Y.T., Wraith, J.E., Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 68 (2007), 99–109, 10.1212/01.wnl.0000251268.41188.04.
3. Spiridigliozzi, G.A., Heller, J.H., Case, L.E., Jones, H.N., Kishnani, P.S., Early cognitive development in children with infantile Pompe disease. Mol. Genet. Metab. 105 (2012), 428–432, 10.1016/j.ymgme.2011.10.012.
4. Bayley, N., Bayley Scales of Infant Development. Second edition, 1993, Psychological Corporation, San Antonio.
5. Piper, M., Darrah, J., Motor Assessment of the Developing Infant: Alberta Infant Motor Scale. first ed., 1994, Saunders Elsevier, St. Louis.
6. Lai, C.-J., Hsu, T.-R., Yang, C.-F., Chen, S.-J., Chuang, Y.-C., Niu, D.-M., Cognitive development in infantile-onset Pompe disease under very early enzyme replacement therapy. J. Child Neurol. 31 (2016), 1617–1621, 10.1177/0883073816665549.
7. Bayley, N., Bayley Scales of Infant and Toddler Development. Third edition, 2006, Psychological Corporation, New York.
8. Yang, C.-F., Yang, C.C., Liao, H.-C., Huang, L.-Y., Chiang, C.-C., Ho, H.-C., Lai, C.-J., Chu, T.-H., Yang, T.-F., Hsu, T.-R., Soong, W.-J., Niu, D.-M., Very early treatment for infantile-onset Pompe disease contributes to better outcomes. J. Pediatr., 169, 2016 174–+ http://dx.doi.org/10.1016/j.jpeds.2015.10.078.
9. Chien, Y.-H., Lee, N.-C., Chen, C.-A., Tsai, F.-J., Tsai, W.-H., Shieh, J.-Y., Huang, H.-J., Hsu, W.-C., Tsai, T.-H., Hwu, W.-L., Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth. J. Pediatr., 166, 2015 985-991–2 10.1016/j.jpeds.2014.10.068.
10. Folio, M.R., Fewell, R., Peabody Developmental Motor Scales. Second edition, 2000, Pro-Ed, Austin.
11. Spiridigliozzi, G.A., Heller, J.H., Kishnani, P.S., Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: long-term follow-up. Am. J. Med. Genet. C Semin. Med. Genet. 160C (2012), 22–29, 10.1002/ajmc.31323.
12. Wechsler, D., Wechsler Preschool and Primary Scale of Intelligence. Third edition, 2002, Psychological Corporation, San Antonio.
13. Wechsler, D., Wechsler Intelligence Scale for Children - Fourth Edition. 2003, Psychological Corporation, San Antonio.
14. Sparrow, S., Cicchetti, D., Balla, D., Vineland Adaptive Behavior Scales. second ed., 2005, Pearson Assessment, Minneapolis.
15. Ebbink, B.J., Aarsen, F.K., van Gelder, C.M., van den Hout, J.M.P., Weisglas-Kuperus, N., Jaeken, J., Lequin, M.H., Arts, W.F.M., van der Ploeg, A.T., Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy. Neurology 78 (2012), 1512–1518.
16. Tellegen, P., Winkel, M., Wijnberg-Williams, B., Laros, J., Snijders Oomen Nonverbal Intelligence Test - Revised. first ed., 2008, Hogrefe, Amsterdam.
17. Griffiths, R., The Abilities of Young Children. second ed., 1984, The Test Agency Limited, Oxford, UK.
18. Griffiths, R., The Abilities of Babies. second ed., 1986, The Test Agency Limited, Oxford, UK.
19. Ebbink, B.J., Poelman, E., Plug, I., Lequin, M.H., van Doorn, P.A., Aarsen, F.K., van der Ploeg, A.T., van den Hout, J.M.P., Cognitive decline in classic infantile Pompe disease: an underacknowledged challenge. Neurology 86 (2016), 1260–1261, 10.1212/WNL.0000000000002523.
20. Messinger, Y.H., Mendelsohn, N.J., Rhead, W., Dimmock, D., Hershkovitz, E., Champion, M., Jones, S.A., Olson, R., White, A., Wells, C., Bali, D., Case, L.E., Young, S.P., Rosenberg, A.S., Kishnani, P.S., Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease. Genet. Med. Off. J. Am. Coll. Med. Genet. 14 (2012), 135–142, 10.1038/gim.2011.4.
21. Ebbink, B.J., Poelman, E., Aarsen, F.K., Plug, I., Lequin, M.H., van Doorn, P.A., Van der Ploeg, A.T., Van den Hout, J.M.P., The emerging neurocognitive profile of classic infantile Pompe disease. J. Inherit. Metab. Dis., 39(Suppl. 1), 2016, S52.
22. Austin, S.L., Hobson-Webb, L., Prater, S.N., Banugaria, S.G., Wang, R., Enterline, D.S., Frush, D.P., Kishnani, P.S., Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy. Mol. Genet. Metab., 117, 2016, S23, 10.1016/j.ymgme.2015.12.185.
23. Rohrbach, M., Klein, A., Köhli-Wiesner, A., Veraguth, D., Scheer, I., Balmer, C., Lauener, R., Baumgartner, M.R., CRIM-negative infantile Pompe disease: 42-month treatment outcome. J. Inherit. Metab. Dis. 33 (2010), 751–757, 10.1007/s10545-010-9209-0.
24. Wechsler, D., Wechsler Preschool and Primary Scale of Intelligence - Fourth Edition. 2012, Pearson Education.
25. Wechsler, D., Wechsler Intelligence Scale for Children - Fifth Edition Administration and Scoring Manual With Supplement. 2014, Pearson.
26. Wechsler, D., Wechsler Adult Intelligence Scale. Fourth edition, 2008, Psychological Corporation, San Antonio.
27. Roid, G.H., Miller, L., Leiter International Performance Scale - Revised. 1997, Stoelting, Co, Wood Dale, IL.
28. Roid, G.H., Leiter International Performance Scale. Third edition, 2013, Stoelting.
29. Woodcock, R., McGrew, K., Mather, N., Woodcock-Johnson III Tests of Achievement. 2001, Riverside Pub, Rolling Meadows, IL.
30. Schrank, F.A., Mather, N., McGrew, K.S., Woodcock-Johnson IV Tests of Achievement. 2014, Riverside Pub, Rolling Meadows, IL.
31. Beery, K., Beery, N., The Beery-Buktenica Developmental Test of Visual-Motor Integration With Supplemental Developmental Tests of Visual Perception and Motor Coordination for Children and Adults and Stepping Stones Age Norms From Birth to Age Six: Administration, Scoring and Teaching Manual. fifth ed., 2006, Pearson, Inc, Minneapolis, MN, USA.
32. Beery, K., Beery, N., Buktenica, N., The Beery-Buktenica Developmental Test of Visual-Motor Integration With Supplemental Developmental Tests of Visual Perception and Motor Coordination for Children and Adults and Stepping Stones Age Norms From Birth to Age Six: Administration, Scoring and Teaching Manual. sixth ed., 2010, Pearson, Inc, Minneapolis, MN, USA.
33. Chien, Y.-H., Lee, N.-C., Peng, S.-F., Hwu, W.-L., Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy. Pediatr. Res. 60 (2006), 349–352, 10.1203/01.pdr.0000233014.84318.4e.
34. Yang, E., Prabhu, S.P., Imaging manifestations of the leukodystrophies, inherited disorders of white matter. Radiol. Clin. N. Am. 52 (2014), 279–319, 10.1016/j.rcl.2013.11.008.
35. Ibrahim, M., Parmar, H.A., Hoefling, N., Srinivasan, A., Inborn errors of metabolism: combining clinical and radiologic clues to solve the mystery. AJR Am. J. Roentgenol. 203 (2014), W315–W327, 10.2214/AJR.13.11154.
36. Jung, R.E., Haier, R.J., The Parieto-Frontal Integration Theory (P-FIT) of intelligence: converging neuroimaging evidence. Behav. Brain Sci., 30, 2007 135-154-187 http://dx.doi.org/10.1017/S0140525X07001185.
37. Fields, R.D., White matter in learning, cognition and psychiatric disorders. Trends Neurosci. 31 (2008), 361–370, 10.1016/j.tins.2008.04.001.